SecBot SecBot
ANALYST-UPGRADE

CME

CME GROUP INC.
BULLISH
Impact 3/10
Horizonmonths Processed5mo ago SECanalyst-CME-keefebru-20260618
Keefe, Bruyette & Woods double upgrade: Market Perform → Outperform
Actionable Insight ▲ Bullish

KBW's high-accuracy upgrade is a bullish signal, but the $305 target is below the median and CEO selling is notable. With earnings on July 21, traders should watch for a catalyst. The upgrade adds conviction to the bullish consensus, but the elevated short interest (55.3%) and insider sales suggest caution. Consider a long position if earnings beat, but hedge with the high short ratio.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$246.38
T+0 close · Jun 18, 2026 · via day close
Latest settled
+13.83%
T+60 · $280.46
Vs SPY
+11.94%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $246.38entry
  2. T+1 · 5mo ago −0.48%α −0.16% · $245.20
  3. T+5 · 5mo ago −8.68%α −7.01% · $225.00
  4. T+20 · 4mo ago −0.04%α −0.58% · $246.27
  5. T+60 · 2mo ago +13.83%α +11.94% · $280.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CME Group Inc. (CME) receives a double upgrade from Keefe, Bruyette & Woods (KBW) to Outperform from Market Perform, with a $305 price target (unchanged from prior). Current price is $252.54, implying 20.8% upside to the target. The upgrade is a contrarian call: KBW's 75% accuracy (6 of 8 calls) and 7.6% average return rank it above the median among 12 firms covering CME. Consensus is split: 10 Buy (including 2 Strong Buy), 8 Hold, 3 Sell, mean target $305.93, median $310, high $353, low $230. KBW's $305 target sits at the 40th percentile of the range, below the median. Momentum is positive: 2 upgrades (including Rothschild & Co to Buy on June 11) vs 0 downgrades in the past 30 days. EPS estimates are being revised higher: 30-day revisions up 3 vs 0 down for 0y and +1y periods. Insider selling is notable: CEO Terrence A. Duffy sold $7.75M on May 15, and director Hilda Piell sold $1.75M on May 18, these sales align with the bearish consensus but are partially offset by a $418K insider buy on March 26. Short interest is 55.3% of float, elevated. Bottom line: KBW's upgrade is a high-accuracy, contrarian call that adds bullish conviction, but the $305 target is below the median, suggesting limited near-term upside. Traders should watch for earnings on July 21 for catalyst.

Impact Score

Base Score
1/7
LLM Adjustment
+2
Final Score
3/10

Consensus & Targets

Buy / Strong Buy
10 (48%)
Hold
8
Sell / Strong Sell
3
Total Analysts
15
Mean PT
$305.93
Median PT
$310.00
High PT
$353.00
Low PT
$230.00
Current Price
$252.54
Implied Upside
+21.1%

Consensus: 10 Buy (2 Strong Buy, 8 Buy), 8 Hold, 3 Sell, 15 analysts total. 67% Buy, 53% Hold, 20% Sell. Direction is bullish but not unanimous. KBW's upgrade to Outperform aligns with the Buy-leaning consensus but is above the median firm's accuracy.

Price targets: mean $305.93, median $310, high $353 (Morgan Stanley), low $230 (JP Morgan). Current price $252.54 implies 21.1% upside to mean, 22.8% to median. KBW's $305 is at the 40th percentile of the range, below the median. The high target ($353) from Morgan Stanley (88% accuracy) is 39.8% above current; the low ($230) from JP Morgan (0% accuracy) is 8.9% below.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-06-18Keefe, Bruyette & WoodsupgradeOutperform$305.00
2026-06-11Rothschild & CoupgradeBuy$323.00
2026-04-23Morgan StanleymaintainOverweight$353.00
2026-04-23BarclaysmaintainEqual-Weight$316.00
2026-04-15Piper SandlermaintainOverweight$329.00
2026-04-13BarclaysmaintainEqual-Weight$343.00
2026-04-10Morgan StanleymaintainOverweight$362.00
2026-04-08BarclaysmaintainEqual-Weight$344.00
2026-03-04Argus ResearchdowngradeHoldNo target
2026-02-05JP MorganmaintainUnderweight$266.00

30-day activity: 2 upgrades (KBW, Rothschild & Co), 0 downgrades. EPS revisions: 30-day revisions up 3 vs 0 down for 0y and +1y periods; 7-day revisions up 1 vs 0 down. Estimates are being revised higher, consistent with the bullish upgrade.

Firm Track Record: Keefe, Bruyette & Woods

Keefe, Bruyette & Woods accuracy: 58% on 2175 calls | avg return: 3.5%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
UBS100%4/43.1%top tier
RBC Capital100%6/67.8%top tier
Deutsche Bank100%5/56.7%top tier
Piper Sandler89%8/98.5%top tier
Morgan Stanley88%7/86.1%top tier
Keefe, Bruyette & Woods75%6/87.6%top tier
Barclays71%10/145.6%top tier
Oppenheimer71%5/73.6%top tier
Citigroup60%3/54.9%above average
Raymond James50%1/20.7%below average

KBW: 75% accuracy (6 of 8), 7.6% avg return, above the 12-firm median (71%). Best: UBS (100%, 3.1% avg), RBC Capital (100%, 7.8%), Deutsche Bank (100%, 6.7%), Piper Sandler (89%, 8.5%). Worst: JP Morgan (0% on 6 calls, 5.9% avg), B of A Securities (0% on 4 calls, 5.1% avg). KBW's accuracy is above the median but below top-tier firms.

Earnings Estimates

Next earnings: Jul 21, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
+1q$2.97$2.80 to $3.16$1.7B↑1 ↓0
0y$12.28$11.91 to $12.62$7.0B↑1 ↓0
+1y$12.92$11.85 to $13.61$7.3B↑1 ↓0
0q$2.98$2.88 to $3.10$1.7B↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
1 buys / 2 sells
Institutional
Vestmark Advisory Solutions, Inc.: add (28.1%)
Institutional
ALLSTATE CORP: add (43.6%)
Institutional
Erste Asset Management GmbH: add (54.4%)
Short Interest
Short: 320,116 | Exempt: 73 | TRF Vol: 579,251 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)

Insider trades: CEO Terrence A. Duffy sold $7.75M (May 15), director Hilda Piell sold $1.75M (May 18), bearish signal. Director William R. Shepard bought $418K (March 26), bullish. Institutional: Allstate Corp added 43.6% ($11.7M), Erste Asset added 54.4% ($29.4M), bullish. Short interest: 55.3% of float (320,116 shares), elevated, bearish. The insider sales (CEO, director) align with the bearish consensus, but the institutional adds and KBW's upgrade create divergence. Short interest is high, suggesting potential squeeze risk.

Investment Themes

Traditional Finance

Documents Analyzed

Report based on filing metadata.

Track record

29 reports on CME

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.81% at T+60 after the Mar 12, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $315.87 Now $319.37 +1.11% settles Feb 9
  2. Nov 9, 20267d ago 144 Neutral 1/10 Entry $304.52 Now $319.37 +4.88% settles Feb 5
  3. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $308.27 Now $319.37 +3.60% settles Feb 2
  4. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  5. Nov 2, 202614d ago 3 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $306.24 Now $319.37 +4.29% settles Jan 29
  8. Oct 27, 202620d ago Insider Cluster Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
  9. Oct 27, 202620d ago 144 Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
  10. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $305.71 Now $319.37 +4.47% settles Jan 21
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (11h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026